Volume 8, Issue 3
Brief Reportp. 311
Childhood arthritis: study identifies 14 new genes as potential treatment targets
Author(s): Bulletin Board
Brief Reportp. 312
Risk of rheumatoid arthritis increases with years spent smoking and number of cigarettes
Author(s): Bulletin Board
Brief Reportp. 312
Zoledronic acid: is there a cloud around the silver lining?
Author(s): Bulletin Board
Brief Reportp. 313
Atomic force microscopy: a force for good in the understanding of osteoarthritis
Author(s): Bulletin Board
Case Reportp. 315
The JAK inhibitor tofacitinib for active rheumatoid arthritis: results from Phase III trials
Author(s): E Salgado & JJ Gomez-Reino
Special Issue Articlep. 327
Epidemiological studies on adipokines and osteoarthritis
Author(s): E Yusuf & M Kloppenburg
Review Articlep. 347
Clinical disease activity assessments in rheumatoid arthritis
Author(s): F Salaffi & A Ciapetti
Review Articlep. 361
Recent updates on the recommendations for the management of ankylosing spondylitis: what and why?
Author(s): RE Schiotis, J Calvo-Gutierrez, A Salas, P Font-Ugalde, MC Castro-Villegas & E Collantes-Estevez
Review Articlep. 373
Therapeutic targeting of T cells in systemic sclerosis
Author(s): R Cant, JM van Laar & S O Reilly
Review Articlep. 383
Biologic response modifiers for granulomatosis with polyangiitis (Wegeners): from promise to reality
Author(s): JM Clain, R Cartin-Ceba & U Specks
Review Articlep. 399
Role of the complement in pregnancy with antiphospholipid syndrome: mechanisms of pathogenesis and clinical aspects
Author(s): S De Carolis, A Vitucci, S Garofalo, S Salvi, G Del Sordo, R Rella & A Botta
Review Articlep. 407
Treating obstetric antiphospholipid syndrome
Author(s): C Galarza-Maldonado, MR Kourilovitch, P Andrade-Sánchez, MC Durán & E Asanza
